Multi-center Clinical Study on Hemoperfusion of KHA80

Exclusion Criteria

• •1. Those who are known to have allergic reactions, contraindications or intolerance to the materials of dialyzers and hemoperfutors;
• •2. Patients with severe bleeding tendency and active bleeding, or with definite coagulation dysfunction, with a platelet count of \< 60× 109/L;
• •3. Hemodialysis blood flow \< 200 ml/min.
• •4. Kt/V\<1.2；
• •5. Serum albumin \< 30g/L;
• •6. Parathyroid resection within one year;
• •7. people with low blood pressure and severe cardiopulmonary insufficiency;
• •8. lactating or pregnant women or those who plan to be pregnant within one year;
• •9. infection, history of malignant tumor, active stage of rheumatic immune disease;
• •10. Patients whose life expectancy is less than one year;
• •11. Other clinical researchers are currently or recently (within 30 days);
• •12. According to the researcher's judgment, the patient has other unsuitable conditions.